Particle.news
Download on the App Store
5 ARTICLES
·
3w ago

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

The court stay gives the FDA time to finish a promised safety review of mifepristone.

Image
A demonstrator holds a box of mifepristone pills in front of the Supreme Court which is hearing arguments related to FDA v. Alliance for Hippocratic Medicine Tuesday, March 26, 2024 in Washington, DC. The case concerns whether to restrict access to a key abortion medication used in more than half of all U.S. abortions and first approved by the Food and Drug Administration in 2000. Tom Brenner for The Washington Post via Getty
Image
Image

Overview

  • U.S. District Judge David Joseph declined to halt mail delivery of mifepristone and stayed Louisiana’s lawsuit, while ordering the FDA to hand over its administrative record within 60 days and to file periodic status updates.
  • The stay is designed to let the FDA complete its safety review, which agency leaders pledged during their confirmations and which has no announced finish date.
  • The Justice Department said it will keep asking courts to allow the FDA’s review to run its course, signaling that litigation strategy remains tied to the agency’s timeline.
  • A coalition of 78 anti-abortion groups urged Acting Attorney General Todd Blanche to back states in suits challenging mail-order abortion pill policies and to drop DOJ support for the FDA’s position.
  • Sen. Josh Hawley asked the DOJ to investigate Danco Laboratories over safety and business practices, citing claims data showing higher complication rates than FDA summaries, and the department confirmed it received his request.